The FDA recently labeled a recall of Abbott (NYSE: ABT) + Abbott Laboratories $105.79 1.58% Open 107.32 Day High 107.32 52 ...
In March, Abbott recalled the Heartmate 3 system after a sealing issue during implant was tied to 70 injuries and two deaths. The company recalled Heartmate II and Heartmate 3 systems in February due ...
UPDATE: May 16, 2024: An Abbott spokesperson wrote in an emailed statement that patients living with a Heartmate system are at “no risk” because of the issue related to the most recent recall.
A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA's most serious recall, the agency announced Monday. The recall comes years after surgeons say ...
People with heart failure can get either short-term or long-term circulation assistance from the Heartmate pump. The heart’s ...
The FDA has deemed two recalls as Class I — Medline Industries for issues with its Sub-G Endotracheal Tube and Abbott for yet another issue with its HeartMate 3 Left Ventricular Assist System.
Customers of an Abbott heart pump have reported 81 incidents, 70 injuries and two deaths related to blood leakage or air entering the device, according to the FDA. The company's HeartMate 3 Left ...
If headlines about Abbott’s HeartMate 3 problems are giving you déjà vu, you’re not alone. With three recalls related to the left ventricular assist device (LVAD) so far this year, the news is ...
Federal health officials said that nearly 14,000 heart devices tied to hundreds of injuries and more than a dozen deaths are being voluntarily recalled. The Department of Justice announced an ...
As Abbott faces its third HeartMate 3 recall this year, the news brings to mind Medtronic's defunct HeartWare device. After Medtronic pulled the plug on its HeartWare left ventricle assist device ...
Heart failure (HF) is a significant factor driving the growth of mechanical circulatory support devices (MCSDs), which are used in three therapies for patients not eligible for heart transplants ...
Abbott is recalling a system monitor used with the Heartmate cardiac pump because screen display issues could pose a risk to patients. The Class 1 recall affects 4,842 monitors distributed in the ...